Artificial intelligence-based computer-aided diagnosis abnormality score trends in the serial mammography of patients with breast cancer
Si Eun Lee, Kyunghwa Han, Miribi Rho, Eun-Kyung Kim
European Journal of Radiology, 2024
Abstract
Purpose
To explore the abnormality score trends of artificial intelligence-based computer-aided diagnosis (AI-CAD) in the serial mammography of patients until a final diagnosis of breast cancer.
Method
From 2015 to 2019, 126 breast cancer patients who had at least two previous mammograms obtained from 2008 up to cancer diagnosis were included. AI-CAD was retrospectively applied to 487 previous mammograms and all the abnormality scores calculated by AI-CAD were obtained. The contralateral breast of each affected breast was defined as the control group. We divided all mammograms by 6-month intervals from cancer diagnosis in reverse chronological order. The random coefficient model was used to estimate whether the chronological trend of AI-CAD abnormality scores differed between cancer and normal breasts. Subgroup analyses were performed according to mammographic visibility, invasiveness and molecular subtype of the invasive cancer.
Results
Mean period from initial examination to cancer diagnosis was 6.0 years (range 1.7–10.7 years). The abnormality scores of breasts diagnosed with cancer showed a significantly increasing trend during the previous examination period (slope 0.6 per 6 months, p for the slope < 0.001), while the contralateral normal breast showed no trend (slope 0.03, p = 0.776). The difference in slope between the cancerous and contralateral breasts was significant (p < 0.001). For mammography-visible cancers, the abnormality scores in cancerous breasts showed a significant increasing trend (slope 0.8, p < 0.001), while for mammography-occult cancers, the trend was not significant (slope 0.1, p = 0.6). For invasive cancers, the slope of the abnormality scores showed a significant increasing trend (slope 1.4, p = 0.002), unlike ductal carcinoma in situ (DCIS) which showed no significant trend. There was no significant difference in the slope of abnormality scores among the subtypes of invasive cancers (p = 0.418).
Conclusion
Breasts diagnosed with cancer showed an increase in AI-CAD abnormality scores in previous serial mammograms, suggesting that AI-CAD could be useful for early detection of breast cancer.